|
Abstract: . . . celecoxib have different odds of nonfatal myocardial in- farction. Ann Intern Med 2005; 142157-64. 48. Shaya FT, Blume SW, Blanchette CM, Weir MR, Mullins CD. Selective cyclooxygenase-2 inhibition and cardiovascular effects. Arch Intern Med 2005; 165: 181-6. Terapia antinfiammatoria e rischio cardiovascolare : cosa fare? 93 1295_REUMA2_03_Editoriale 25-05-2006 17:37 Pagina 93 . . . . . . celecoxib have different odds of nonfatal myocardial in- farction. Ann Intern Med 2005; 142157-64. 48. Shaya FT, Blume SW, Blanchette CM, Weir MR, Mullins CD. Selective cyclooxygenase-2 inhibition and cardiovascular effects. Arch Intern Med 2005; 165: 181-6. Terapia antinfiammatoria e rischio cardiovascolare : cosa fare? 93 1295_REUMA2_03_Editoriale 25-05-2006 17:37 Pagina 93 . . . . . . different odds of nonfatal myocardial in- farction. Ann Intern Med 2005; 142157-64. 48. Shaya FT, Blume SW, Blanchette CM, Weir MR, Mullins CD. Selective cyclooxygenase-2 inhibition and cardiovascular effects. Arch Intern Med 2005; 165: 181-6. Terapia antinfiammatoria e rischio cardiovascolare : cosa fare? 93 1295_REUMA2_03_Editoriale 25-05-2006 17:37 Pagina 93 . . . . . . myocardial in- farction. Ann Intern Med 2005; 142157-64. 48. Shaya FT, Blume SW, Blanchette CM, Weir MR, Mullins CD. Selective cyclooxygenase-2 inhibition and cardiovascular effects. Arch Intern Med 2005; 165: 181-6. Terapia antinfiammatoria e rischio cardiovascolare : cosa fare? 93 1295_REUMA2_03_Editoriale 25-05-2006 17:37 Pagina 93 . . . . . . in- farction. Ann Intern Med 2005; 142157-64. 48. Shaya FT, Blume SW, Blanchette CM, Weir MR, Mullins CD. Selective cyclooxygenase-2 inhibition and cardiovascular effects. Arch Intern Med 2005; 165: 181-6. Terapia antinfiammatoria e rischio cardiovascolare : cosa fare? 93 1295_REUMA2_03_Editoriale 25-05-2006 17:37 Pagina 93 . . . --3000,5,300,2448,55960
|